Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Genetics · Proximal 18q Deletion Syndrome

What is Proximal 18q Deletion Syndrome?

At a Glance

Proximal 18q Deletion Syndrome is a rare genetic condition caused by a missing piece in the middle of chromosome 18. Symptoms vary but often include developmental delays, speech challenges, and immune or endocrine issues. Care requires early intervention therapies and multidisciplinary medical monitoring.

Receiving a diagnosis of Proximal 18q Deletion Syndrome (also known as Proximal 18q-) often brings a mix of relief at finally having an answer and a deep sense of overwhelm [1]. It is important to know that you have entered a small, dedicated community. This condition is significantly rarer than the more common “distal” version of the syndrome, meaning many doctors you meet may never have seen a case before [1]. While the road ahead involves many questions, understanding the basics can help you feel more grounded as you begin this journey.

Understanding the Syndrome

Chromosomes are the instruction manuals for the body, and each person typically has two copies of chromosome 18. Proximal 18q Deletion Syndrome occurs when a piece of the “long arm” (q) of one of these chromosomes is missing near the center (the proximal region) [1].

Because this deletion happens in the middle of the chromosome rather than at the tip, it is called an interstitial deletion [1]. This is distinct from distal 18q-, which involves the tip of the chromosome and has a different set of common features [1]. While this diagnosis is most often made in young children experiencing developmental delays, adults can also be diagnosed [2].

Why the Presentation Varies

You may hear that this syndrome is a spectrum or “highly variable” [3][4]. This variability exists because no two deletions are exactly the same. The “proximal” region of 18q is large, and the specific genes missing will determine the unique health profile [1][5].

  • Gene dosage: Some genes are “dosage-sensitive,” meaning the body needs both copies to function perfectly. If a critical gene like TCF4 is included in the deletion, it can lead to more specific challenges, such as those seen in Pitt-Hopkins syndrome [5].
  • Critical regions: Researchers have identified specific “breakpoints” or regions on the chromosome that are more likely to be linked to certain features, such as heart defects or significant developmental delays [1].

Stabilizing Facts

In the wake of a rare diagnosis, it is helpful to focus on what is known and actionable.

  1. It is not your fault: This deletion typically occurs randomly (a de novo event) in the egg or sperm or shortly after conception. There is nothing anyone did or did not do to cause this [1].
  2. Growth and development continue: While individuals with Proximal 18q- often face developmental delays (hitting milestones like walking or talking later than peers), they continue to learn, gain new skills, and reach milestones in their own time [1][6].
  3. Proactive monitoring works: Many of the health concerns associated with the syndrome, such as thyroid issues or growth hormone deficiencies, are highly manageable with early intervention and standard medical treatments [7][8].

Medical and Developmental Spectrum

While every person is different, research points to several areas that require consistent monitoring:

  • Neurodevelopment: Most individuals experience some degree of intellectual disability or learning challenges. Expressive speech (the ability to speak) is often more delayed than receptive speech (the ability to understand) [1][6].
  • Immune Health: Some individuals may have immunodeficiencies (a weakened immune system), making them more prone to recurrent infections. Regular monitoring of immune function is recommended [9].
  • Endocrine System: Problems with the thyroid or growth hormone levels are common. Some children benefit significantly from recombinant human growth hormone (rhGH) therapy to address short stature [7][8].
  • Physical Health: The care team will likely recommend baseline “one-time” checks, such as an echocardiogram to look at the heart and an abdominal ultrasound to check the kidneys, as structural differences in these organs can occur [1][2].

Moving Forward

Management of Proximal 18q- is multidisciplinary, meaning it involves a team of specialists (like geneticists, neurologists, and therapists) working together [10]. Early access to therapies, including Physical Therapy (PT), Occupational Therapy (OT), and Speech Therapy, is considered the standard of care to help individuals reach their full potential [1][10].

Common questions in this guide

What causes Proximal 18q Deletion Syndrome?
It is caused by a missing piece of genetic material in the middle of the long arm of chromosome 18. This usually happens randomly during conception as a 'de novo' event, meaning it is not caused by anything the parents did or did not do.
What is the difference between proximal and distal 18q deletion?
A proximal deletion happens in the middle of the chromosome, which is called an interstitial deletion. A distal deletion involves the very tip of the chromosome, resulting in a different set of symptoms and health concerns.
Will a child with Proximal 18q- be able to learn and develop?
Yes. While individuals with this syndrome often experience developmental delays and speak later than their peers, they do continue to learn, gain new skills, and reach developmental milestones at their own pace.
What health screenings are needed right after a diagnosis?
Your care team will likely recommend an echocardiogram to check the heart and an abdominal ultrasound to look at the kidneys. Regular monitoring of the immune system and endocrine system, including the thyroid, is also standard practice.
What treatments are available for Proximal 18q Deletion Syndrome?
Management involves a multidisciplinary team approach. Early intervention with physical, occupational, and speech therapies is considered the standard of care. Specific medical treatments, such as human growth hormone therapy, may also be used to address short stature.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are the exact chromosomal coordinates (breakpoints) of the deletion on the microarray report?
  2. 2.Which specific medically significant genes are missing in this region?
  3. 3.What baseline screenings (like an echocardiogram or blood work) should be scheduled immediately?
  4. 4.When should we schedule our first appointments with specialists like endocrinology or immunology?
  5. 5.What specific therapies (OT, PT, Speech) do you recommend starting given this diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Clinical delineation of 18q11-q12 microdeletion: Intellectual disability, speech and behavioral disorders, and conotruncal heart defects.

    Rojnueangnit K, Charalsawadi C, Thammachote W, et al.

    Molecular genetics & genomic medicine 2019; (7(9)):e896 doi:10.1002/mgg3.896.

    PMID: 31390163
  2. 2

    18q Deletion Syndrome-Associated Schizophrenia: A Case Report.

    Colijn MA, Crockford DN

    Neuropsychobiology 2024; (83(3-4)):179-182 doi:10.1159/000538693.

    PMID: 38684151
  3. 3

    Terminal microdeletion of chromosome 18 in a Malaysian boy characterized with few features of typical 18q- deletion syndrome: a case report.

    Ismail A, Ahid F, Thong MK, Zakaria Z

    Journal of medical case reports 2023; (17(1)):250 doi:10.1186/s13256-023-03984-0.

    PMID: 37296475
  4. 4

    The genotype and phenotype of chromosome 18p deletion syndrome: Case series.

    Jin Q, Qiang R, Cai B, et al.

    Medicine 2021; (100(18)):e25777 doi:10.1097/MD.0000000000025777.

    PMID: 33950970
  5. 5

    18q21.1q21.32 Deletion in a Patient With Juvenile Cerebral Infarction.

    Obara K, Inomata T

    Cureus 2023; (15(7)):e42534 doi:10.7759/cureus.42534.

    PMID: 37521594
  6. 6

    Case report: genetic analysis of a child with 18q deletion syndrome and developmental dysplasia of the hip.

    Yu S, Wang C, Lei K, et al.

    BMC medical genomics 2022; (15(1)):199 doi:10.1186/s12920-022-01345-2.

    PMID: 36123715
  7. 7

    Subcutaneous immunoglobulin replacement therapy in a patient with 18q deletion syndrome, primary immune deficiency, and type 1 diabetes.

    Hogendorf A, Szadkowska A, Michalak A, et al.

    International journal of immunopathology and pharmacology 2021; (35()):20587384211039400 doi:10.1177/20587384211039400.

    PMID: 34514903
  8. 8

    Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.

    Liu S, Chen M, Yang H, et al.

    Frontiers in endocrinology 2021; (12()):776835 doi:10.3389/fendo.2021.776835.

    PMID: 34956087
  9. 9

    18q Deletion Syndrome Presenting with Late-Onset Combined Immunodeficiency.

    Hashiguchi S, Tomomasa D, Nishikawa T, et al.

    Journal of clinical immunology 2024; (44(7)):154 doi:10.1007/s10875-024-01751-4.

    PMID: 38896123
  10. 10

    Growth hormone treatment in a patient with deletion of the long arm of chromosome 18: An 8-year observation.

    Jackowski T, Petriczko E, Horodnicka-Jozwa A, et al.

    Neuro endocrinology letters 2019; (40(4)):169-174.

    PMID: 32087092

This page provides educational information about Proximal 18q Deletion Syndrome. It is not a substitute for professional medical advice or genetic counseling. Always consult your healthcare provider or geneticist to interpret specific microarray results.

Get notified when new evidence is published on Proximal chromosome 18q deletion syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.